de Koster, E.J.; Sulaiman, T.; Hamming, J.F.; Schepers, A.; Snel, M.; van Velden, F.H.P.; de Geus-Oei, L.-F.; Vriens, D.
Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment? Diagnostics 2021, 11, 553.
https://doi.org/10.3390/diagnostics11030553
AMA Style
de Koster EJ, Sulaiman T, Hamming JF, Schepers A, Snel M, van Velden FHP, de Geus-Oei L-F, Vriens D.
Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment? Diagnostics. 2021; 11(3):553.
https://doi.org/10.3390/diagnostics11030553
Chicago/Turabian Style
de Koster, Elizabeth J., Taban Sulaiman, Jaap F. Hamming, Abbey Schepers, Marieke Snel, Floris H. P. van Velden, Lioe-Fee de Geus-Oei, and Dennis Vriens.
2021. "Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?" Diagnostics 11, no. 3: 553.
https://doi.org/10.3390/diagnostics11030553
APA Style
de Koster, E. J., Sulaiman, T., Hamming, J. F., Schepers, A., Snel, M., van Velden, F. H. P., de Geus-Oei, L.-F., & Vriens, D.
(2021). Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment? Diagnostics, 11(3), 553.
https://doi.org/10.3390/diagnostics11030553